Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles DeYoung

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Pediatric Ophthalmology and Strabismus|January 25, 2023
Cavitary Retinoblastoma Imaged on Magnetic Resonance ImagingCharles DeYoung, Matthew R Barke, Carol L Shields
Seminars in Arthritis and Rheumatism|August 27, 2021
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United StatesRahul Raiker, Charles DeYoung, Haig Pakhchanian, et al.
Ophthalmic Genetics|March 23, 2022
<i>De novo</i> frameshift mutation in <i>YAP1</i> associated with bilateral uveal coloboma and microphthalmiaCharles DeYoung, Bin Guan, Ehsan Ullah, et al.
Journal of Autoimmunity|October 15, 2021
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research networkRahul Raiker, Haig Pakhchanian, Charles DeYoung, et al.
Investigative Ophthalmology & Visual Science|October 1, 2025
TYROSINASE-Deficient Human Retinal Pigment Epithelium Exhibits Melanosome Maturation DefectsAman George, Tyler Pfister, Charles DeYoung, et al.
International Ophthalmology|September 14, 2023
Ophthalmology procedure trends in the United States during the COVID-19 pandemicCharles DeYoung, Masumi G Asahi, Sedona Rosenberg, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|February 21, 2024
Impact of iris color on uveal melanoma-related outcomes in 7245 patients at a single ocular oncology centerAlexandra R Zaloga, Charles DeYoung, Deepthi E Kurian, et al.
Stem Cell Reports|January 12, 2022
In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epitheliumAman George, Ruchi Sharma, Tyler Pfister, et al.
Molecular Therapy. Advances|May 15, 2026
Gene therapy induces pigmentation in induced pluripotent stem cell-derived retinal pigment epithelium of OCA1A patients and albino rat eyeAman George, Arnold Leigh, Evan Selzer, et al.
Journal of Vitreoretinal Diseases|October 22, 2025
The Efficacy and Safety of Intravitreal Aflibercept 8 mg in Clinical PracticeBrandon A Bates, Hana A Mansour, Hasenin Al-Khersan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Pediatric Ophthalmology and Strabismus|January 25, 2023
Cavitary Retinoblastoma Imaged on Magnetic Resonance ImagingCharles DeYoung, Matthew R Barke, Carol L Shields
Seminars in Arthritis and Rheumatism|August 27, 2021
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United StatesRahul Raiker, Charles DeYoung, Haig Pakhchanian, et al.
Ophthalmic Genetics|March 23, 2022
<i>De novo</i> frameshift mutation in <i>YAP1</i> associated with bilateral uveal coloboma and microphthalmiaCharles DeYoung, Bin Guan, Ehsan Ullah, et al.
Journal of Autoimmunity|October 15, 2021
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research networkRahul Raiker, Haig Pakhchanian, Charles DeYoung, et al.
Investigative Ophthalmology & Visual Science|October 1, 2025
TYROSINASE-Deficient Human Retinal Pigment Epithelium Exhibits Melanosome Maturation DefectsAman George, Tyler Pfister, Charles DeYoung, et al.
International Ophthalmology|September 14, 2023
Ophthalmology procedure trends in the United States during the COVID-19 pandemicCharles DeYoung, Masumi G Asahi, Sedona Rosenberg, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|February 21, 2024
Impact of iris color on uveal melanoma-related outcomes in 7245 patients at a single ocular oncology centerAlexandra R Zaloga, Charles DeYoung, Deepthi E Kurian, et al.
Stem Cell Reports|January 12, 2022
In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epitheliumAman George, Ruchi Sharma, Tyler Pfister, et al.
Molecular Therapy. Advances|May 15, 2026
Gene therapy induces pigmentation in induced pluripotent stem cell-derived retinal pigment epithelium of OCA1A patients and albino rat eyeAman George, Arnold Leigh, Evan Selzer, et al.
Journal of Vitreoretinal Diseases|October 22, 2025
The Efficacy and Safety of Intravitreal Aflibercept 8 mg in Clinical PracticeBrandon A Bates, Hana A Mansour, Hasenin Al-Khersan, et al.
Pageof 2